000 | 01300 a2200373 4500 | ||
---|---|---|---|
005 | 20250513114036.0 | ||
264 | 0 | _c19970417 | |
008 | 199704s 0 0 eng d | ||
022 | _a0013-9580 | ||
024 | 7 |
_a10.1111/j.1528-1157.1997.tb04512.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJohannessen, S I | |
245 | 0 | 0 |
_aPharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. _h[electronic resource] |
260 |
_bEpilepsia _c1997 |
||
300 |
_aS18-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAcetates _xpharmacokinetics |
650 | 0 | 4 | _aAmines |
650 | 0 | 4 |
_aAnticonvulsants _xpharmacokinetics |
650 | 0 | 4 | _aCyclohexanecarboxylic Acids |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aDrug Monitoring |
650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
650 | 0 | 4 |
_aFructose _xanalogs & derivatives |
650 | 0 | 4 | _aGabapentin |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLamotrigine |
650 | 0 | 4 | _aTopiramate |
650 | 0 | 4 |
_aTriazines _xpharmacokinetics |
650 | 0 | 4 | _aVigabatrin |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xanalogs & derivatives |
773 | 0 |
_tEpilepsia _gvol. 38 Suppl 1 _gp. S18-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1528-1157.1997.tb04512.x _zAvailable from publisher's website |
999 |
_c9076390 _d9076390 |